Core 3: Communications, Administrations, Advocacy, and Project Management
核心 3:沟通、行政、宣传和项目管理
基本信息
- 批准号:10628613
- 负责人:
- 金额:$ 26.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBreast Cancer TreatmentBudgetsClinicalClinical Drug DevelopmentCollaborationsCommunicationElementsEnsureFriendsGenerationsGoalsHuman ResourcesIndividualInfrastructureLeadershipMagnetic Resonance ImagingMeasurableMeasuresMethodologyModificationOffice of Administrative ManagementOutcomeParticipantPatient-Focused OutcomesPatientsProgram Research Project GrantsProtocols documentationRegimenRegulatory PathwayReportingResearch PersonnelRoleScienceSequential TreatmentSpecific qualifier valueStructureSubgroupTrainingTranslatingTranslational ResearchWorkdesignimaging biomarkerimprovedmalignant breast neoplasmmeetingsmolecular markernext generationnoveloperationpersonalized medicineprogramsresponse biomarkerrestrainttimelinetooltreatment responsetreatment strategytrial designwebinarworking group
项目摘要
The Program Project encompasses four integrated projects to develop and maintain the infrastructure for developing and
implementing improvements in the I-SPY2.2 trial that employs early escalation/de-escalation of treatment and identifies
treatment strategies to optimize patient outcomes within a regulatory evidence generation framework. The primary aims
of the Communications, Administration, Advocacy, and Project management (CAAP) Core are to ensure program
integration, collaboration, patient acceptance, and regulatory compliance by providing project management, leadership,
and administrative support to all Projects and Cores; as well as the integration of advocacy in all patient-facing aspects of
the Projects and Core in the Program Project.
Perhaps the most critical role of the CAAP core is to coordinate the activities and deliverables of the projects and cores
with the study sponsor QLHC, its clinical operations team and the I-SPY2 trial working group chairs. While program
project personnel, cores and projects are tasked with developing and refining the technical and methodological advances
required in the continuous improvement approach employed in I-SPY2.2, all operational aspects of the trial are the
responsibility of the study sponsor. The Program Project overall PIs and project PIs, facilitated by the CAAP core, work
to integrate the changes into the operations of the trial with sponsor representatives by defining the technical
requirements, specifications, and deliverables for the sponsor’s clinical operations team.
Among its other responsibilities, the CAAP Core ensures that our patient advocates are represented on all project teams,
cores teams and inter-project collaborations, so that they can bring their unique and important perspective to help meet the
patient-centric mandate of I-SPY2.2.
Specific Aim 1: Organize, integrate, and provide administrative management of all Projects and Core
Specific Aim 2: Provide project management oversight to track milestones and timelines of the individual Projects and
Cores.
Specific Aim 3: Facilitate collaborations and disseminate information
该计划项目包括四个集成项目,以开发和维护开发和
在I-SPY2.2试验中实施改进
在监管证据生成框架内优化患者结果的治疗策略。主要目的
沟通,管理,倡导和项目管理(CAAP)核心是确保计划
通过提供项目管理,领导才能,集成,协作,患者接受和监管合规性
以及对所有项目和核心的行政支持;以及在所有面向患者的方面的倡导的整合
计划项目中的项目和核心。
CAAP核心最关键的作用也许是协调项目和核心的活动和可交付成果
研究赞助商QLHC,其临床运营团队和I-SPY2试验组椅子。程序
项目人员,核心和项目的任务是发展和完善技术和方法论进步
在I-SPY2.2中进行的连续改进方法中,试验的所有操作方面都是
研究学者的责任。该计划项目整体PI和PIS PIS,由CAAP核心促进,工作
通过定义技术,将更改与赞助商代表代表的试验运营中
赞助商的临床运营团队的要求,规格和可交付成果。
在其其他职责中,CAAP核心确保我们的患者拥护者在所有项目团队中都有代表
核心团队和项目间合作,以便他们可以带来独特而重要的观点,以帮助实现
I-SPY2.2的以患者为中心的任务。
特定目标1:组织,整合并提供所有项目和核心的行政管理
特定目标2:提供项目管理监督,以跟踪各个项目的里程碑和时间表
内核。
特定目标3:促进合作并传播信息
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA J ESSERMAN其他文献
LAURA J ESSERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA J ESSERMAN', 18)}}的其他基金
Enhancing the Diversity of Participants in the WISDOM Clinical Trial: Practical Challenges and Ethical Implications
增强 WISDOM 临床试验参与者的多样性:实际挑战和伦理影响
- 批准号:
10367828 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10368970 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10593908 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
9888251 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
I-SPY2:改进 I-SPY 2 试验,纳入 MRI 引导的适应性序贯治疗,以优化乳腺癌结果
- 批准号:
9789198 - 财政年份:2017
- 资助金额:
$ 26.66万 - 项目类别:
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
I-SPY2:改进 I-SPY 2 试验,纳入 MRI 引导的适应性序贯治疗,以优化乳腺癌结果
- 批准号:
10013133 - 财政年份:2017
- 资助金额:
$ 26.66万 - 项目类别:
相似国自然基金
基于倡导促动理论的老年人多重慢病健康管理策略研究:理论模型、行为模式与管理路径
- 批准号:71874104
- 批准年份:2018
- 资助金额:50.0 万元
- 项目类别:面上项目
相似海外基金
myAURA: Personalized Web Service for Epilepsy Management
myAURA:用于癫痫管理的个性化 Web 服务
- 批准号:
10414826 - 财政年份:2021
- 资助金额:
$ 26.66万 - 项目类别:
Geriatric Oncology Research Infrastructure to Improve Clinical Care
改善临床护理的老年肿瘤学研究基础设施
- 批准号:
10667860 - 财政年份:2018
- 资助金额:
$ 26.66万 - 项目类别:
How Does an Academically-Oriented Kindergarten Classroom Impact Children's Outcomes?
以学术为导向的幼儿园课堂如何影响儿童的学习成果?
- 批准号:
9035701 - 财政年份:2015
- 资助金额:
$ 26.66万 - 项目类别: